ArticlePloS one2017

Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis.

Masanobu Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.